XHS ranks 4th and KURE 23rd of 25 funds in the Health Care (Broad) Category.
KURE vs XHS
XHS −0.30pt a year
0.65%0.35%
KURE 2.5×the volume
80.8K31.9K
XHS +15.4pt
−9.3%+6.1%
KURE vs XHS Performance
−38.5%+34.4%
- KURE 0.65%
- XHS 0.35%, better
- KURE $108M
- XHS $234M
- KURE −6.6%
- XHS +38.0%, better
- KURE 4.12%, better
- XHS 0.15%
- KURE 44
- XHS 63
- KURE 80.8K sh, better
- XHS 31.9K sh
- KURE $17.55
- XHS $144.25
ETF.net Grade
| Pillar | KURE | XHS |
|---|---|---|
| Cost | D27 | A81Higher |
| Mission | ||
| Risk | F9 | A78Higher |
| Tradability | F24 | C54Higher |
| Holdings | C52 | A87Higher |
| Durability | D36 | B64Higher |
Rank among Health Care (Broad) funds
Same Category. KURE and XHS are both graded against the same 25 Health Care (Broad) funds, so their Grades compare head to head.
Our read on each fund
KURED
XHSA
In short
KURE The US-listed route into China's health care sector in one ticker: about 50 Chinese pharma and medical names listed in the Mainland, Hong Kong and the US. A narrow, volatile slice of a huge market, not a broad pharma fund.
XHS Most health care ETFs are pharma funds in disguise. XHS buys the delivery system instead: insurers, hospitals, distributors and clinics, roughly equal weighted so one giant insurer does not run the show.
Stated mandate
KURE KURE is designed to track the MSCI China All Shares Healthcare 10/40 Index, which represents Chinese companies engaged in the healthcare sector.
XHS The fund seeks to track the total return of the S&P Health Care Services Select Industry Index before fees and expenses, providing targeted exposure to health care services companies.
Why people hold it
Worth knowing
KURE vs XHS Holdings
How we measure overlap
Each holding counts at its smaller weight in the two funds, summed over the full Holdings. Sector, country and asset class use the same rule on each fund’s split. Cash, FX and derivative lines stay out of the counts. Two bond funds get no overlap figure.
KURE vs XHS Cost
Overpaying KURE vs XHS
$5,591
On $10,000 over 30 years. 7% growth a year before fees, expense ratio only.
KURE 0.65%
$12,717
XHS 0.35%
$7,126
Cost over time
Year by year
| Year | KURE | XHS | Overpaying |
|---|---|---|---|
| 10 | $1,163 | $634 | $529 |
| 20 | $4,440 | $2,454 | $1,986 |
| 30 | $12,717 | $7,126 | $5,591 |
- 0.65%KURE
- 0.35%XHS, cheaper
- Middle half of Health Care (Broad) funds
- Median 0.50%
XHS 5th cheapest of 25 funds
KURE 18th cheapest of 25 funds
KURE vs XHS Dividends
- KURE 4.12%, better
- XHS 0.15%
- KURE $0.71
- XHS $0.21
- KURE $0.71
- XHS $0.01
- KURE Dec 22, 2025
- XHS Sep 21, 2026
- KURE Dec 23, 2025
- XHS Sep 23, 2026
- KURE Annual
- XHS Quarterly
Distribution history
KURE vs XHS Risk
Fall from peak · 5 years
- KURE
- XHS
Risk facts
- Volatility
- KURE 26.5%XHS 20.8%, better
- Return per unit of risk
- KURE −0.02XHS 0.85, better
- Worst fall
- KURE −58.6%XHS −30.0%, better
- Market sensitivity
- KURE 0.30XHS 0.93
KURE and XHS in the news
Popular comparisons
- 0.65% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.08%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.65% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
- 0.35% · 0.09%
- Same Category. Both funds are graded against the same funds, so their Grades compare head to head.
